News Search Results | Healthcare News Journal

Weight Control Drug Belviq May Raise Cancer Risk: FDA

Jan 18, 2020 , MedicineNet

Title: Weight Control Drug Belviq May Raise Cancer Risk: FDACategory: Health NewsCreated: 1/16/2020 12:00:00 AMLast Editorial Review: 1/17/2020 12:00:00...

Diet Drug Belviq May Raise Cancer Risk: FDA

Jan 17, 2020 , WebMD

Health care providers should weigh the benefits of taking lorcaserin against the potential risks when deciding whether to prescribe or continue patients on the medication, the FDA...

Romaine Lettuce OK To Eat Again: CDC Declares End To Months-Long Ban Due To E-Coli

Jan 17, 2020 , Kaiser Health News

The FDA says it's going to continue to investigate the source of the outbreak that led to the hospitalization of 85 people beginning in September. No one...

U.S. FDA panel split over approval of Durect's non-opioid painkiller

Jan 17, 2020 , Reuters

Independent experts on an FDA advisory panel on Thursday were split over the approval of Durect Corp's non-opioid painkiller to manage post-surgical pain....

FDA-backed CBD drug brings in $296 million in 'incredible launch year,' GW Pharma CEO says

Jan 17, 2020 , CNBC Health

"It's an incredible launch year for any medication [that] I think proves that this kind of medicine is really making a difference to patients," GW Pharma CEO Justin Gover told CNBC's Jim...

New Drugs Getting FDA's Blessing Faster, but Is That a Good Thing?

Jan 16, 2020 , MedicineNet

Title: New Drugs Getting FDA's Blessing Faster, but Is That a Good Thing?Category: Health NewsCreated: 1/14/2020 12:00:00 AMLast Editorial Review: 1/15/2020 12:00:00...

Weight loss drug Belviq tied to 'possible increased risk of cancer,' FDA says

Jan 16, 2020 , CNN Health

The US Food and Drug Administration warns that prescription weight loss medicine Belviq might be associated with an increased risk of cancer....

New Drugs Getting FDA's Blessing Faster, but Is That a Good Thing?

Jan 16, 2020 , WebMD

The result is that patients are being prescribed pricey new medications that have not been tested as rigorously, said lead researcher Jonathan Darrow, an assistant professor at Harvard Medical...

FDA Clears First Nasal Spray for Cluster Seizures

Jan 16, 2020 , eMedicine Health

FDA Clears First Nasal Spray for Cluster Seizures in Kids 6 Years and...

Akili Interactive: Digital pediatric ADHD therapeutic performs well with or without accompanying stimulant therapy

Jan 16, 2020 dave.muoio@himssmedia.com (Dave Muoio), Mobile Health News

Topline data released today by the digital therapeutics company also suggest that its FDA approval-pending treatment continued to deliver benefits with continued...

FDA Clears First Nasal Spray for Cluster Seizures in Kids 6 Years and Older

Jan 16, 2020 , RxList

The US Food and Drug Administration (FDA) has approved diazepam nasal spray (Valtoco, Neurelis) in patients with epilepsy aged 6 and older for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity such as seizure clusters and acute repetitive seizures that are distinct from a patient's usual seizure...

FDA Warning: Weight Loss Drug Belviq May Increase Cancer Risk

Jan 15, 2020 , Forbes

The FDA has released a public alert regarding the safety of weight loss drug lorcaserin after a clinical trial assessing safety of the drug showed that it may increase the risk of...

Prescription Fish Oil: 5 Things to Know

Jan 15, 2020 , RxList

Fish oil supplements for cardiovascular (CV) protection have been a controversial topic for years. Recently, Vascepa (Amarin), a prescription fish oil comprising high-dose icosapent ethyl, received an expanded indication from the US Food and Drug Administration (FDA) for CV risk reduction in some patients with elevated triglyceride (TG) levels. Given that not all fish oil products — prescription or over-the-counter — are alike, here are five important things to know about their...

FDA approval may not be as rigorous as it once was

Jan 15, 2020 , Reuters

Changes in U.S. Food and Drug Administration (FDA) procedures meant to speed approvals for medications may have resulted in less exacting standards, a new analysis suggests....

Nektar withdraws application for opioid painkiller after FDA panel's vote

Jan 15, 2020 , Reuters

Nektar Therapeutics said on Tuesday it was withdrawing the application for its opioid painkiller for adults with chronic low back pain, after a U.S. Food and Drug Administration (FDA) panel unanimously voted against the drug's approval....

The Future Of Clinical Trials? Here Is A Simulation Model Of The Heart

Jan 14, 2020 , Forbes

In 2014 Dassault Systèmes began working with the FDA and a network of surgeons, cardiologists, and other researchers and scientists. Here's what's happened since....

US FDA clears NuvoAir's connected spirometer device

Jan 10, 2020 dave.muoio@himssmedia.com (Dave Muoio), Mobile Health News

The Air Next is designed for patients with respiratory conditions such as asthma, COPD and cystic...

FDA approves Blueprint's stomach cancer therapy priced at $32,000 per month

Jan 10, 2020 , Reuters

The U.S. Food and Drug Administration approved Blueprint Medicines Corp's oral therapy to treat a rare form of cancer that affects the stomach and small intestine, the agency said on Thursday....

Merck's Keytruda wins U.S. FDA approval for bladder cancer

Jan 09, 2020 , Reuters

The U.S. Food and Drug Administration said on Wednesday it approved Merck & Co Inc's Keytruda for a hard-to-treat form of bladder cancer, making it the first new treatment for the cancer in more than two decades....

Why Did The FDA Deny Approval For A Monthly HIV Injection Treatment?

Jan 08, 2020 , Forbes

Developers hoped that the monthly injection would replace daily pills, thus making life easier for HIV patients and also possibly removing some of the stigma associated with the disease....